These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 9631844)
1. Incidence, outcome, and risk factors of cerebrovascular events in patients undergoing maintenance hemodialysis. Kawamura M; Fijimoto S; Hisanaga S; Yamamoto Y; Eto T Am J Kidney Dis; 1998 Jun; 31(6):991-6. PubMed ID: 9631844 [TBL] [Abstract][Full Text] [Related]
2. Infective endocarditis in maintenance hemodialysis patients: fifteen years' experience in one medical center. Chang CF; Kuo BI; Chen TL; Yang WC; Lee SD; Lin CC J Nephrol; 2004; 17(2):228-35. PubMed ID: 15293522 [TBL] [Abstract][Full Text] [Related]
3. Prevalence and determinants of hypertension in chronic hemodialysis patients in Japan. Iseki K; Nakai S; Shinzato T; Morita O; Shinoda T; Kikuchi K; Wada A; Kimata N; Akiba T Ther Apher Dial; 2007 Jun; 11(3):183-8. PubMed ID: 17497999 [TBL] [Abstract][Full Text] [Related]
4. Staff-assisted nursing home haemodialysis: patient characteristics and outcomes. Reddy NC; Korbet SM; Wozniak JA; Floramo SL; Lewis EJ Nephrol Dial Transplant; 2007 May; 22(5):1399-406. PubMed ID: 17259652 [TBL] [Abstract][Full Text] [Related]
5. Incidence of gallstones in chronic renal failure patients undergoing hemodialysis: experience of a center in Turkey. Altiparmak MR; Pamuk ON; Pamuk GE; Celik AF; Apaydin S; Cebi D; Mihmanli I; Erek E Am J Gastroenterol; 2003 Apr; 98(4):813-20. PubMed ID: 12738461 [TBL] [Abstract][Full Text] [Related]
6. Hyperhomocysteinemia is a significant risk factor for silent cerebral infarction in patients with chronic renal failure undergoing hemodialysis. Anan F; Takahashi N; Shimomura T; Imagawa M; Yufu K; Nawata T; Nakagawa M; Yonemochi H; Eshima N; Saikawa T; Yoshimatsu H Metabolism; 2006 May; 55(5):656-61. PubMed ID: 16631443 [TBL] [Abstract][Full Text] [Related]
7. Incidence of strokes and its prognosis in patients on maintenance hemodialysis. Onoyama K; Kumagai H; Miishima T; Tsuruda H; Tomooka S; Motomura K; Fujishima M Jpn Heart J; 1986 Sep; 27(5):685-91. PubMed ID: 3820579 [TBL] [Abstract][Full Text] [Related]
8. [Cardiovascular risk markers in hemodialysis]. Urso S; Milone F; Garozzo M; Cannavò ME; Biondi A; Battaglia G G Ital Nefrol; 2004; 21 Suppl 30():S212-6. PubMed ID: 15750988 [TBL] [Abstract][Full Text] [Related]
9. Predictors for silent cerebral infarction in patients with chronic renal failure undergoing hemodialysis. Anan F; Shimomura T; Imagawa M; Masaki T; Nawata T; Takahashi N; Yonemochi H; Eshima N; Saikawa T; Yoshimatsu H Metabolism; 2007 May; 56(5):593-8. PubMed ID: 17445532 [TBL] [Abstract][Full Text] [Related]
10. The effects of intravenous iron treatment on oxidant stress and erythrocyte deformability in hemodialysis patients. Cavdar C; Temiz A; Yeniçerioğlu Y; Calişkan S; Celik A; Sifil A; Onvural B; Camsari T Scand J Urol Nephrol; 2003; 37(1):77-82. PubMed ID: 12745750 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study. Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306 [TBL] [Abstract][Full Text] [Related]
12. Nutritional status of twice and thrice-weekly hemodialysis patients with weekly Kt/V > 3.6. Supasyndh O; Satirapoj B; Seenamngoen S; Yongsiri S; Choovichian P; Vanichakarn S J Med Assoc Thai; 2009 May; 92(5):624-31. PubMed ID: 19459522 [TBL] [Abstract][Full Text] [Related]
13. [Hypertension in hemodialysis patients in Andalucia]. García Cortés MJ; Ceballos M; Nefrologia; 2004; 24(2):149-57. PubMed ID: 15219090 [TBL] [Abstract][Full Text] [Related]
15. Determinants of prescribed dialysis dose and survival in a cohort of chronic hemodialysis patients. Iseki K; Tozawa M; Takishita S Clin Exp Nephrol; 2003 Sep; 7(3):231-7. PubMed ID: 14586720 [TBL] [Abstract][Full Text] [Related]
16. Superior outcome of nafamostat mesilate as an anticoagulant in patients undergoing maintenance hemodialysis with intracerebral hemorrhage. Yang JW; Han BG; Kim BR; Lee YH; Kim YS; Yu JM; Choi SO Ren Fail; 2009; 31(8):668-75. PubMed ID: 19814633 [TBL] [Abstract][Full Text] [Related]